Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Current Deferred Revenue (2019 - 2024)

Pulmatrix's Current Deferred Revenue history spans 6 years, with the latest figure at $270000.0 for Q2 2024.

  • For Q2 2024, Current Deferred Revenue fell 75.65% year-over-year to $270000.0; the TTM value through Jun 2024 reached $270000.0, down 75.65%, while the annual FY2023 figure was $618000.0, 53.85% down from the prior year.
  • Current Deferred Revenue for Q2 2024 was $270000.0 at Pulmatrix, down from $363000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $12.0 million in Q1 2020 and bottomed at $270000.0 in Q2 2024.
  • The 5-year median for Current Deferred Revenue is $1.4 million (2022), against an average of $2.7 million.
  • The largest annual shift saw Current Deferred Revenue crashed 89.82% in 2021 before it soared 42.6% in 2022.
  • A 5-year view of Current Deferred Revenue shows it stood at $4.2 million in 2020, then plummeted by 77.46% to $939000.0 in 2021, then soared by 42.6% to $1.3 million in 2022, then tumbled by 53.85% to $618000.0 in 2023, then tumbled by 56.31% to $270000.0 in 2024.
  • Per Business Quant, the three most recent readings for PULM's Current Deferred Revenue are $270000.0 (Q2 2024), $363000.0 (Q1 2024), and $618000.0 (Q4 2023).